Atle Fund Management AB
Top Portfolio Positions
39 positions ·
$463,383,762 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
617,245 | $60,027,076 | 12.95% | |
| DXCM |
Dexcom Inc
Healthcare
|
584,332 | $36,696,049 | 7.92% | |
| LLY |
ELI LILLY & Co
Healthcare
|
39,722 | $36,535,103 | 7.88% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
70,851 | $32,661,602 | 7.05% | |
| ABBV |
AbbVie Inc.
Healthcare
|
108,181 | $23,528,285 | 5.08% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
1,169,634 | $23,264,020 | 5.02% | |
| CAH |
Cardinal Health Inc
Healthcare
|
108,682 | $22,965,593 | 4.96% | |
| JNJ |
Johnson & Johnson
Healthcare
|
92,377 | $22,580,633 | 4.87% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
195,768 | $18,085,047 | 3.90% | |
| CELC |
Celcuity Inc.
Healthcare
|
141,296 | $16,127,525 | 3.48% |
Portfolio Trend
19 quarters · across all stocks
Holdings in NAMS
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,034,419 | 94,796 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,912,022 | 197,036 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,506,695 | 193,625 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,847,308 | 157,223 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $2,206,318 | 107,783 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,571,863 | 138,983 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,307,117 | 138,983 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,456,002 | 75,794 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $529,618 | 22,394 | Shares | Sole | 2024-04-25 | |
| No 13F history on record for this holder in this stock. | ||||||